Showing results (591-600 of 831) with videos related to

Sort By:
Pageof 84
Plos One|December 24, 2011
A two-gene signature, SKI and SLAMF1, predicts time-to-treatment in previously untreated patients with chronic lymphocytic leukemiaCarmen D Schweighofer, Kevin R Coombes, Lynn L Barron, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2005
Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemiaMichael J Keating, Susan O'Brien, Maher Albitar, et al.
The Journal of Molecular Diagnostics : JMD|August 11, 2007
Identification and validation of biomarkers of IgV(H) mutation status in chronic lymphocytic leukemia using microfluidics quantitative real-time polymerase chain reaction technologyLynne V Abruzzo, Lynn L Barron, Keith Anderson, et al.
Molecular Cancer Research : MCR|May 20, 2014
STAT3-activated GM-CSFRα translocates to the nucleus and protects CLL cells from apoptosisPing Li, David Harris, Zhiming Liu, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 5, 2012
A randomized controlled trial of an intensive insulin regimen in patients with hyperglycemic acute lymphoblastic leukemiaKhanh Vu, Naifa Busaidy, Maria E Cabanillas, et al.
Frontiers in Oncology|September 14, 2013
The Addition of All-Trans Retinoic Acid to Chemotherapy May Not Improve the Outcome of Patient with NPM1 Mutated Acute Myeloid LeukemiaAziz Nazha, Carlos Bueso-Ramos, Eli Estey, et al.
British Journal of Haematology|June 19, 2012
Elacytarabine has single-agent activity in patients with advanced acute myeloid leukaemiaSusan O'Brien, David A Rizzieri, Norbert Vey, et al.
Leukemia & Lymphoma|May 26, 2020
Incidence and risk of tumor lysis syndrome in patients with relapsed chronic lymphocytic leukemia (CLL) treated with venetoclax in routine clinical practiceAmber B Koehler, Nelson Leung, Timothy G Call, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2006
Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemiaTait D Shanafelt, Thomas E Witzig, Stephanie R Fink, et al.
British Journal of Haematology|September 16, 2009
Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progressionWei Ding, Grzegorz S Nowakowski, Traci R Knox, et al.
Pageof 84